Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11891393 Functionalized heterocycles as antiviral agents

Patent 11891393 was granted and assigned to Enanta Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Enanta Pharmaceuticals
Enanta Pharmaceuticals
0
Date Filed
November 3, 2021
0
Date of Patent
February 6, 2024
0
Patent Applicant
Enanta Pharmaceuticals
Enanta Pharmaceuticals
0
Patent Application Number
17517740
0
Patent Citations
‌
US Patent 7615569 Inhibitors of ion channels
0
‌
US Patent 7232825 Phenylaminopyrimidine derivatives and methods of use
0
‌
US Patent 7312214 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors
0
‌
US Patent 7411003 Inhibition of Hepatitis B virus by cyclohexenone compounds from
0
‌
US Patent 9938301 Dihydropyrimido fused ring derivative as HBV inhibitor
0
‌
US Patent 10179131 Hepatitis B antiviral agents
0
‌
US Patent 10179792 Hepatitis B antiviral agents
0
‌
US Patent 10189846 Hepatitis B antiviral agents
0
‌
US Patent 10253030 Crystal form, preparation method and intermediate of dihydropyrido ring compound
0
‌
US Patent 10428070 Hepatitis B antiviral agents
0
•••
Patent Inventor Names
Samuel Bartlett
0
Joseph Panarese
0
Dexter Davis
0
Nathaniel Kenton
0
Yat Sun Or
0
Katherine Chong
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11891393
0
Patent Primary Examiner
‌
Charanjit Aulakh
0
CPC Code
‌
A61P 31/12
0
‌
A61P 31/20
0
‌
C07D 471/14
0
‌
A61K 31/4985
0

Find more entities like US Patent 11891393 Functionalized heterocycles as antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.